JMKX003948
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JMKX003948, covering 2024-07-09 to 2024-07-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma [Phase 1]